Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Depressed that DUPA rules me out of a transplant

      in Chat  8 upvotes 3 years ago
      A user is upset about hair loss due to seborrheic dermatitis and DUPA, which prevents a hair transplant. They mention using jojoba oil and discuss treatments like Minoxidil, finasteride, and RU58841.

      community 3ish months in w topical min. Happy but should I expect more?

      in Progress Pictures  65 upvotes 1 year ago
      The conversation is about a user who has been using topical minoxidil for 3 months and oral finasteride for 2.5 years to combat hair loss, with positive results so far. The user is curious about future hair growth and considers additional treatments like dermarolling and low-level laser therapy.

      community Anyone get results with Ru58841?

      in Treatment  6 upvotes 5 months ago
      RU58841 stopped shedding after two weeks and improved hair after eight months. Initial thinning may occur within the first month.

      community Topical advice? How to cover head with 1mL?

      in Treatment  10 upvotes 3 years ago
      The conversation is about how to effectively apply 1mL of a topical hair loss treatment, Pyrilutamide, to cover the entire scalp. One user suggests making a 2.5 mg/mL solution and using 2mL for better coverage.

      community Shedding whilst on Dut and topical min

      in Chat  2 upvotes 5 months ago
      A 26-year-old from the UK is experiencing increased hair thinning despite using dutasteride and topical minoxidil. They are considering additional treatments like ketoconazole shampoo, oral minoxidil, and possibly RU58841, while seeking advice on managing side effects and exploring other options.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.